887 studies found for:    Pulmonary Disease, Chronic Obstructive: Clinical Trials
Show Display Options
Rank Status Study
21 Recruiting A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK2269557;   Drug: Placebo;   Device: DISKUS
22 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Osteopenia
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
23 Completed Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice
Condition: Lung Diseases, Obstructive
Interventions: Behavioral: an integrated self-management education program;   Behavioral: regular practice nurse review (monitoring controls);   Behavioral: care at initiative of the patient (usual GP care)
24 Active, not recruiting The International Nocturnal Oxygen (INOX) Trial
Conditions: Chronic Obstructive Pulmonary Disease;   Nocturnal Desaturation
Interventions: Device: Concentrator;   Device: Sham concentrator
25 Unknown  A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Salbutamol (Ventolin®);   Drug: Formoterol (Oxis Turbuhaler®);   Drug: Salmeterol / fluticasone (Seretide®);   Drug: Bufei granule;   Drug: Bufeijianpi granule;   Drug: Bufeiyishen granule;   Drug: Yiqizishen granule;   Drug: conventional medicine + TCM
26 Recruiting A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Umeclidinium bromide;   Drug: Placebo
27 Completed Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
Conditions: COPD;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: SUN-101 50 mcg BID eFlow (CS) nebulizer;   Drug: SUN-101 25 mcg BID eFlow (CS) nebulizer;   Drug: Placebo eFlow (CS) nebulizer
28 Completed Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Fluticasone 500mcg BD via accuhaler or identical placebo
29 Completed Home Mechanical Ventilation vs Home Oxygen Therapy in COPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Device: Home mechanical ventilation;   Device: Long term oxygen therapy
30 Recruiting Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo ELLIPTA device;   Drug: Placebo capsules for use in HANDIHALER device;   Other: Inhaler Preference Questionnaire Version 1;   Other: Inhaler Preference Questionnaire Version 2
31 Not yet recruiting A Trial to Study the Effects of Pulmonary Rehabilitation Program on Exercise Capacity and Quality of Life in Patients With Severe Form of Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Rehabilitation
Intervention: Other: Pulmonary Rehabilitation
32 Completed Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Ipratropium bromide HFA-134a inhalation aerosol;   Drug: Atrovent CFC inhalation aerosol
33 Completed Discharge Coordinator Intervention in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Coordinated discharge;   Other: Control
34 Completed Pilot Randomized Controlled Trial of a Breathlessness Intervention Service for Chronic Obstructive Pulmonary Disease
Condition: Dyspnea
Interventions: Behavioral: Breathlessness Intervention Service (BIS);   Behavioral: Best supportive care (Standard care)
35 Completed Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Behavioral: Relaxation Response (instruction, pocket practice card prov);   Behavioral: Mindfulness training using model developed from UMass
36 Completed
Has Results
Association Between Increased Oxidative Stress, Anti-Inflammatory Fatty Acid Formation, and Airway Infection in People With Asthma and Chronic Obstructive Pulmonary Disease
Conditions: Asthma;   Pulmonary Disease, Chronic Obstructive
Intervention:
37 Completed A Randomized Controlled Trial to Determine Outcome and Cost Effectiveness of Case Management of Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Behavioral: Case Management
38 Completed Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Behavioral: Physical activity self-management;   Other: COPD education + Usual care
39 Recruiting A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone furoate (FF);   Drug: vilanterol (VI);   Drug: umeclidinium bromide (UMEC)
40 Completed COPD on Primary Care Treatment (COOPT)
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive;   Bronchitis, Chronic
Interventions: Drug: N-acetylcysteine;   Drug: fluticasone propionate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years